Loading…

INMIND: A PHASE 3 STUDY OF TAFASITAMAB + LENALIDOMIDE AND RITUXIMAB VS PLACEBO + LENALIDOMIDE AND RITUXIMAB FOR RELAPSED/REFRACTORY FOLLICULAR OR MARGINAL ZONE LYMPHOMA

Saved in:

Bibliographic Details
Published in:	Hematological oncology 2021-06, Vol.39 (S2)
Main Authors:	Hübel, K., Scholz, C. W., Luminari, S., Salar, A., Wahlin, B. E., Gopal, A. K., Bonnet, C., Trneny, M., Paneesha, S., Manzke, O., Seguy, F., Li, D., Sehn, L. H.
Format:	Article
Language:	English
Subjects:	Immunotherapy Lymphoma Monoclonal antibodies Placebos Rituximab Targeted cancer therapy
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!